Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.2000 |
Strike | 0.50 |
Expiry date | 2024-09-20 |
Day's range | 0.0500 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 11 |
Insights into Geron Corp's robust financial standing and strategic updates, including FDA discussions and trial timelines.
Geron (GERN) delivered earnings and revenue surprises of 10% and 102.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?